Showing posts with label #QualityofLife. Show all posts
Showing posts with label #QualityofLife. Show all posts

Friday, March 8, 2024

❤️IMSPARK: Improved Heart Care for Pacific Veterans❤️

❤️Imagine... Improved Heart Care for Pacific Veterans❤️



💡 Imagined Endstate: 

A future where Pacific veterans receive the highest standard of cardiac care, with state-of-the-art bedside assessments that ensure early detection and treatment of heart conditions.

🔗Link: 

📚Source: 

VA News. (2024). Improving Veteran bedside cardiac assessment. 

💥 What’s the Big Deal: 

The big deal is the transformative impact on veterans’ healthcare quality in the Pacific. 🌊By improving bedside cardiac assessments, veterans gain access to more accurate diagnoses and personalized care plans.🏥 This advancement is not just about better health outcomes;🩺 it’s about showing our veterans 🎖️that their sacrifices are honored through dedicated, compassionate care that meets their specific needs. It’s a commitment to enhancing their quality of life and providing peace of mind to them and their families.


#VeteransCare, #CardiacCare, #HeartHealth,#MedicalInnovation, #CompassionateCare,#QualityofLife,#IMSPARK, 



Monday, February 26, 2024

💊Imagine... Improved Survival and Quality of Life for Pancreatic Cancer Patients💊

💡 Imagined Endstate

Pacific region will adopt and implement the new first-line treatment option for metastatic pancreatic cancer.

🔗Link: 

Ref Here

📚Source: 

Post, E. (2024, February 13). FDA Approves New First-line Treatment Option for Metastatic Pancreatic Cancer: What You Need to Know. Pancreatic Cancer Action Network.

💥 What’s the Big Deal: 

By  access and affordability to this treatment, the Pacific region will improve the outcomes and well-being of its pancreatic cancer patients, who often face poor prognoses and limited options.🌊Pancreatic cancer is often diagnosed late when it spreads to other organs and is difficult to treat.

 To treat metastatic pancreatic cancer, doctors typically use 2 chemotherapy drugs - gemcitabine and nab-paclitaxel. This treatment approach has shown a median overall survival rate of 9.2 months. The new treatment, NALIRIFOX, is a combination of three chemotherapy drugs, liposomal irinotecan, oxaliplatin, and fluorouracil/leucovorin, which has a median overall survival of 11.1 months.🎗️This is the first new first-line treatment for metastatic pancreatic cancer approved by the FDA in over ten years. The Pacific region has the opportunity and responsibility to make this treatment available and affordable for its pancreatic cancer patients, who deserve a better chance of living longer and better.


#PancreaticCancer, #Pacific, #NewTreatment, #Survival,#QualityofLife,#HealthAccess,#Innovation,#IMSPARK,

Sunday, November 12, 2023

🛂 IMSPARK: Deciphering the Allure of U.S. Immigration🛂

Imagine... Deciphering the Allure of U.S. Immigration



                                                   (Image Courtesy of Visual Capitalist)

💡 Imagined Endstate:  

In an ideal future, a comprehensive understanding of the motivations behind immigration to the United States has been attained.

📚 Source: 

Wallach, O. (2023, November 4). Why Do People Immigrate to the U.S.? Visual Capitalist.

🔗 Link:

Read More

💥 What's the Big Deal: 

The United States has been a magnet for immigrants from around the world, 🗺️and their motivations for immigrating are diverse.📸 Understanding the various reasons behind immigration 🗽is crucial for shaping inclusive and effective immigration policies. This visualization provides insights into the categories and origins of U.S. immigrants, 🌆shedding light on the factors that drive people to seek a new life in the United States. 📰This knowledge enables informed policies and international cooperation on migration issues.


#immigration,#QualityofLife,#US,#internationalCooperation,#VisualCapitalist,#IMSPARK, 


🔬 IMSPARK: Unveiling New Climate Insights🔬

🔬 Imagine... Unveiling New Climate Insights🔬 💡 Imagined Endstate :  A world enlightened by groundbreaking climate science, guiding target...